Blood cancer refers to cancers that originate in the blood and bone marrow. Hematology and Oncology Research is actively engaged in studying these cancers to discover better treatments and therapies for patients. Some of the most common types of blood cancers include leukemia, lymphoma, and myeloma. Leukemia is the…
Blood cancer refers to cancers that originate in the blood and bone marrow. Hematology and Oncology Research is actively engaged in studying these cancers to discover better treatments and therapies for patients. Some of the most common types of blood cancers include leukemia, lymphoma, and myeloma. Leukemia is the most common type of blood cancer, and it begins in the bone marrow where blood cells are produced. The cancerous cells can either be chronic (slow-growing) or acute (fast-growing) and can affect both children and adults. The cancerous cells can spill out into the bloodstream and travel throughout the body, leading to symptoms like fatigue, weakness, and susceptibility to infections. Lymphoma is another type of blood cancer that impacts the lymphatic system. This type of cancer develops when white blood cells called lymphocytes begin to grow and divide without stopping. While lymphoma can occur at any age, it is more common among people over 60. Patients with lymphoma may experience swelling in the lymph nodes, fever, and weight loss. Myeloma arises when the plasma cells in the bone marrow become cancerous. These cells play a critical role in the immune system by producing antibodies that help fight infections. Myeloma can weaken the immune system and lead to anemia, kidney damage, and bone problems. In the field of Hematology and Oncology Research, scientists are always looking for new ways to treat blood cancers. Treatments can include chemotherapy, radiation therapy, and bone marrow transplants. Targeted therapies, which attack specific cancer cell proteins, are also being developed for some types of blood cancers. The aim is to create a personalized approach to treatment that will lead to better outcomes and a higher quality of life for patients.
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 4 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Common Blood Cancers, linking to each citing work.